Cargando…
The smoking-dyslipidaemia dyad: A potent synergistic risk for atherosclerotic coronary artery disease
BACKGROUND: Smoking and dyslipidaemia are known individual risk factors of coronary artery disease (CAD). The present study examined the combined risk of smoking and dyslipidaemia on coronary atherosclerosis. METHODS: Coronary artery calcium (CAC), measured by cardiac CT, was used to assess the exte...
Autores principales: | Prakash, Vineet, Jaker, Sams, Burgan, Amjad, Jacques, Adam, Fluck, David, Sharma, Pankaj, Fry, Christopher H, Han, Thang S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968041/ https://www.ncbi.nlm.nih.gov/pubmed/33796280 http://dx.doi.org/10.1177/2048004020980945 |
Ejemplares similares
-
Sex differences in the agreement between left ventricular ejection
fraction measured by myocardial perfusion scintigraphy and by
echocardiography
por: Jaker, Sams, et al.
Publicado: (2020) -
Current Insights on Dyslipidaemia Management for Prevention of Atherosclerotic Cardiovascular Disease: A Malaysian Perspective
por: Wan Ahmad, Wan Azman, et al.
Publicado: (2023) -
Diabetic dyslipidaemia
por: C. Thambiah, Subashini, et al.
Publicado: (2021) -
Changing trends in the use of novel oral anticoagulants and warfarin for treating non-valvular atrial fibrillation
por: Birkinshaw, Alexander, et al.
Publicado: (2020) -
Associations between smoking and blood-group, and the risk of dyslipidaemia amongst French women
por: MacDonald, C. J., et al.
Publicado: (2021)